Table 1.
Treatment 1 | Treatment 2 | 95% Confidence intervals | P-value | ||
---|---|---|---|---|---|
Lower | Upper | ||||
Rotarod | Sham | WT-NPC | −0.0347 | −0.0003 | 0.0468* |
HD-shHD-NPC | −0.0375 | −0.0087 | 0.0026* | ||
HD-NPC | −0.0352 | 0.0242 | 0.7103 | ||
HD-NPC | WT-NPC | −0.0183 | 0.0423 | 0.4297 | |
HD-shHD-NPC | −0.0123 | 0.0474 | 0.2422 | ||
HD-shHD-NPC | WT-NPC | −0.0176 | 0.0064 | 0.3479 | |
Grip strength | Sham | WT-NPC | −0.0762 | −0.0201 | 0.0014* |
HD-shHD-NPC | −0.0750 | −0.0124 | 0.0077* | ||
HD-NPC | −0.0550 | 0.0290 | 0.5356 | ||
HD-NPC | WT-NPC | −0.0042 | 0.0745 | 0.0785 | |
HD-shHD-NPC | −0.0129 | 0.0743 | 0.1629 | ||
HD-shHD-NPC | WT-NPC | −0.0158 | 0.0247 | 0.6563 |
Rotarod and grip strength tests of HD mice with different treatments were compared using Fisher’s protected LSD test implemented post-hoc on linear regressions to identify differences. For rotarod, HD mice that received intrastriatal WT-NPC injection showed significant improvement compared to the sham injection group (P = 0.0468), and mice that received intrastriatal HD-shHD-NPC showed considerable improvement (P = 0.0026). For grip strength, HD mice that received intrastriatal WT-NPC and HD-shHD-NPC injection showed significant improvement compared to the sham injection group (P = 0.0014, P = 0.0077, respectively) (* denotes P < 0.05)